Neuroleptic malignant syndrome after venlafaxine.
Lancet
; 355(9200): 289-90, 2000 Jan 22.
Article
em En
| MEDLINE
| ID: mdl-10675082
ABSTRACT
A patient developed neuroleptic malignant syndrome after a single dose of venlafaxine with trifluoperazine treatment. A dopamine-inhibition effect induced by one dose of venlafaxine may have augmented dopamine-receptor inhibition by trifluoperazine.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antidepressivos de Segunda Geração
/
Cicloexanóis
/
Síndrome Maligna Neuroléptica
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Lancet
Ano de publicação:
2000
Tipo de documento:
Article